Microsurgery

ZEISS ABIS III: Fully Automated Surface Inspection for Smart Factories

Retrieved on: 
Wednesday, June 28, 2023
Database, Plastic, Health, Classification, MAPLE, Research, Multimedia, Smart products, Science, National Institute of Metrology Standardization and Industrial Quality, Carl Zeiss AG, Investment, Ophthalmology, Microsurgery, Consumer, ZEISS, Aircraft, ABIS, Carl-Zeiss-Stiftung, Software, Telescopic sight

MAPLE GROVE, Minn. , June 28, 2023 /PRNewswire/ --ZEISS Industrial Quality Solutions present the new generation of the surface inspection system ABIS. The new sensor ZEISS ABIS III, enables reliable and early inspection of the entire component surface – within cycle time – due to its objective evaluation and classification of all kinds of defects – making the fully automated system the ideal quality assurance tool for modern press shops and future-oriented body shops.  

Key Points: 
  • MAPLE GROVE, Minn. , June 28, 2023 /PRNewswire/ --ZEISS Industrial Quality Solutions present the new generation of the surface inspection system ABIS.
  • The smart combination of projector, cameras, patented lighting and the new software ZEISS ABIS V20 ensures the perfect balance between maximum inspection speed, robustness, reliability and usability.
  • In quality assurance, the new surface inspection system thus constantly provides all fundamental data needed for targeted rework, quick surface analyses and process optimizations.
  • The software ZEISS ABIS V20 processes and visualizes potential component defects in pressed parts or in complete body-in-whites in real time.

Medical Display Market worth $2.9 billion | MarketsandMarkets

Retrieved on: 
Thursday, May 25, 2023
Telehealth, Medicine, Calibration, Electronics, LG Electronics, Display, DICOM, Research, Endoscopy, Quest International, Google Images, Operating, Investment, Machine learning, Algorithm, Michael Porter, MP, Microsurgery, Artificial intelligence, Diagnosis, Barco (manufacturer), LG, Health, Barco, SME, Software, Video game, Television, Medical imaging, Eizo

Enhanced image quality: Medical displays provide high-resolution and accurate visualization of medical images, enabling healthcare professionals to make precise diagnoses and treatment decisions.

Key Points: 
  • Enhanced image quality: Medical displays provide high-resolution and accurate visualization of medical images, enabling healthcare professionals to make precise diagnoses and treatment decisions.
  • Versatility: The medical display market offers a wide range of display sizes and configurations to suit different clinical settings.
  • Medical Display market - Report Highlights:
    The current edition of the report consists of an updated market overview.
  • Additional points in the market overview have been added, keeping in mind the impact of Recession impact on the overall medical display market.

Medical Display Market worth $2.9 billion | MarketsandMarkets

Retrieved on: 
Thursday, May 25, 2023
Telehealth, Medicine, Calibration, Electronics, LG Electronics, Display, DICOM, Research, Endoscopy, Quest International, Google Images, Operating, Investment, Machine learning, Algorithm, Michael Porter, MP, Microsurgery, Artificial intelligence, Diagnosis, Barco (manufacturer), LG, Health, Barco, SME, Software, Video game, Television, Medical imaging, Eizo

Enhanced image quality: Medical displays provide high-resolution and accurate visualization of medical images, enabling healthcare professionals to make precise diagnoses and treatment decisions.

Key Points: 
  • Enhanced image quality: Medical displays provide high-resolution and accurate visualization of medical images, enabling healthcare professionals to make precise diagnoses and treatment decisions.
  • Versatility: The medical display market offers a wide range of display sizes and configurations to suit different clinical settings.
  • Medical Display market - Report Highlights:
    The current edition of the report consists of an updated market overview.
  • Additional points in the market overview have been added, keeping in mind the impact of Recession impact on the overall medical display market.

SightMD Physicians named 2023 Super Doctors® and Rising Stars

Retrieved on: 
Monday, May 15, 2023
Medicine, Editorial board, Paratriathlon, DO, MD, Patient, Premature, Neuro-ophthalmology, Forehead, World Golf Village, Corneal transplantation, Face, Friends, Orbit, Research, Rockville Centre, New York, Super, Uveitis, Optic nerve, Entrepreneurship, New York Eye and Ear Infirmary, Textbook, Cataract, Abstract, Osteopathic medicine in the United States, Good Samaritan Hospital, Eye, Eyelid, Publishing, Clinical research, Engineering, Microsurgery, Family, Surgeon, CXL, Education, Cross-link, Physician, Hall, Fellow, Pleasure, Rare-earth element, Medical device, Nursing, Dentistry, Veterinary medicine, Ophthalmology, Glaucoma, PRK, Retina, LASIK

HAUPPAUGE, N.Y., May 15, 2023 /PRNewswire-PRWeb/ -- SightMD is excited to announce the growing list of providers that have been named on the 2023 "Super Doctor" and "Super Doctors Rising Stars" lists.

Key Points: 
  • SightMD is excited to announce the growing list of providers that have been named on the 2023 "Super Doctor" and "Super Doctors Rising Stars" lists.
  • HAUPPAUGE, N.Y., May 15, 2023 /PRNewswire-PRWeb/ -- SightMD is excited to announce the growing list of providers that have been named on the 2023 "Super Doctor" and "Super Doctors Rising Stars" lists.
  • said Dr. Baharestani "It is an honor to provide our patients with the highest level oculoplastic surgery services at SightMD."
  • "I am truly honored to be selected as a Super Doctors Rising Star for the 5th year in a row."

EQS-News: Carl Zeiss Meditec achieves double-digit growth in first half year of 2022/23 with declining earnings

Retrieved on: 
Tuesday, May 9, 2023
Strategic business unit, Diagnosis, Marketing, COVID-19, Tax, Research, EBIT, Ophthalmology, Microsurgery, Growth, SBU, Pharmaceutical industry, Retail

Carl Zeiss Meditec generated revenue of around €974.5m in the first six months of fiscal year 2022/23 (prior year: €855.4m), equating to growth of +13.9% (adjusted for currency effects: +12.4%).

Key Points: 
  • Carl Zeiss Meditec generated revenue of around €974.5m in the first six months of fiscal year 2022/23 (prior year: €855.4m), equating to growth of +13.9% (adjusted for currency effects: +12.4%).
  • At the same time, we shall continue our strategic investments in research and development at a fast pace,” says Dr. Markus Weber, President and CEO of Carl Zeiss Meditec AG.
  • Carl Zeiss Meditec AG plans to continue its high strategic investments in sales and marketing and research and development in the second half of fiscal year 2022/23.
  • Carl Zeiss Meditec AG has therefore consolidated its projections for fiscal year 2022/23.

Denver Plastic Surgeons at Grossman Capraro Plastic Surgery Named NewBeauty Top Doctors

Retrieved on: 
Thursday, May 4, 2023
Microsurgery, Beauty, Health, Safety, Patient, Nursing, Dentistry

DENVER, May 4, 2023 /PRNewswire/ -- NewBeauty is pleased to announce that Grossman Capraro Plastic Surgery in Denver, Colorado has been selected to join the 2023 Top Doctor Program.

Key Points: 
  • DENVER, May 4, 2023 /PRNewswire/ -- NewBeauty is pleased to announce that Grossman Capraro Plastic Surgery in Denver, Colorado has been selected to join the 2023 Top Doctor Program.
  • Board-certified plastic surgeons Dr. Philip A. Capraro and Dr. Teresa C. Cunningham are thrilled to be included in this prestigious group of leading aesthetic doctors.
  • Dr. Capraro is a board-certified plastic surgeon with more than two decades of experience in the field of plastic and reconstructive surgery.
  • We look forward to working with NewBeauty to continue to bring the latest advancements in aesthetic medicine to our patients."

Global and Regional Surgical Robotics Market Analysis and Forecasts, 2022-2023 & 2032 - ResearchAndMarkets.com

Retrieved on: 
Friday, April 28, 2023
Technology, Robotics, Health, Surgery, Partnership, RA, Bed, MHLW, Ion, COVID-19, Cancer, Ministry of Health, Labour and Welfare, Curie Institute (Paris), Trial of the century, Ministry, Hospital, Patient, Johnson & Johnson, Microsurgery, Artificial intelligence, DePuy Synthes, Growth, Region, FDA, Ministry of Health, Intuitive Surgical, CMR Surgical, Safety, Country, Medical device, Pharmaceutical industry

The "Surgical Robotics Market - A Global and Regional Analysis: Focus on Type, Application, End-user, and Country - Analysis and Forecast, 2022-2032" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Surgical Robotics Market - A Global and Regional Analysis: Focus on Type, Application, End-user, and Country - Analysis and Forecast, 2022-2032" report has been added to ResearchAndMarkets.com's offering.
  • The increasing demand for minimally invasive surgeries, increasing demand for robotic-assisted surgeries, and increasing synergetic activities within the surgical robotics industry are some of the major opportunities in the global surgical robotics market.
  • The COVID-19 pandemic has impacted practically all sectors and social functions worldwide, including the global surgical robotics market.
  • The global surgical robotics market based on the end-user segment is dominated by the hospitals segment.

MMI Named One of Fast Company’s 2023 “World’s Most Innovative Companies”

Retrieved on: 
Thursday, March 2, 2023
Robotics, Health, Medical Devices, Technology, Surgery, Health Technology, General Health, Wrist, Artery, Head, Surgeon, CE marking, NASA, Microsurgery, Early stage innovation company, MMI, Patient, Vein, Organization, Editorial, Fatigue, MrBeast, Medical device, Tremor, Frasier, ZEUS robotic surgical system, Nursing, Dentistry

MMI , (Medical Microinstruments, Inc.), a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced it has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2023, earning the No.

Key Points: 
  • MMI , (Medical Microinstruments, Inc.), a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced it has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2023, earning the No.
  • MMI was recognized for its state-of-the-art Symani® Surgical System , which has the smallest wristed instruments in the surgical robotics market.
  • The World’s Most Innovative Companies is Fast Company’s signature franchise and one of its most highly anticipated editorial efforts of the year.
  • MMI was included on the list for its efforts to change the landscape of microsurgery to make it more accessible and broaden its applications.

Ancora Finance Group leads the Series A financing of Atlas medical technologies GmbH

Retrieved on: 
Tuesday, January 24, 2023
Workflow, Patient, Injection, Microsurgery, Elective surgery, Gesellschaft mit beschränkter Haftung, Medical device

Atlas medical technologies GmbH strengthens equity by 2.4 million euros in Series A.

Key Points: 
  • Atlas medical technologies GmbH strengthens equity by 2.4 million euros in Series A.
  • Ancora Finance Group is an international company headquartered in London, which sees its expertise in the areas of finance, leadership, strategy and operations of young growth companies.
  • "The financing by our new partner and investors Ancora Finance Group is a milestone in our development and encourages us on our way forward in Europe.
  • ", says Dr. Timo Krüger, CEO of Atlas medical technologies GmbH.

EQS-News: Carl Zeiss Meditec achieves further revenue growth in Q1 2022/23 – Orders on hand remain high

Retrieved on: 
Sunday, February 12, 2023
Marketing, SBU, Environment, Growth, Pressure, Diagnosis, Microsurgery, Tax, Investment, IOL, EBIT, Research, Film, Ophthalmology

Carl Zeiss Meditec generated revenue of €470.3m in the first quarter of fiscal year 2022/23 (prior year: €410.2m), corresponding to growth of +14.6% (adjusted for currency effects: +12.1%).

Key Points: 
  • Carl Zeiss Meditec generated revenue of €470.3m in the first quarter of fiscal year 2022/23 (prior year: €410.2m), corresponding to growth of +14.6% (adjusted for currency effects: +12.1%).
  • “In a challenging environment with continued pressure on the supply chains and lockdowns in the important Chinese market, we still managed to achieve further growth.
  • At the same time, we are also continuously investing in our future growth,” says Dr. Markus Weber, President and CEO of Carl Zeiss Meditec AG, commenting on the first quarter.
  • The strategic business unit Microsurgery achieved revenue growth of +12.9% (adjusted for currency effects: +10.3%) to €112.0m (prior year: €99.3m).